Urakami Tatsuhiko
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Ann Pediatr Endocrinol Metab. 2018 Sep;23(3):113-118. doi: 10.6065/apem.2018.23.3.113. Epub 2018 Sep 28.
It is well known that the incidence of youth-onset type 2 diabetes is increasing worldwide. On the other hand, most studies have shown that the majority of youth-onset type 2 diabetes occurs in obese individuals, generally with a body mass index (BMI) greater than the 90th or 95th centile for sex- and age-matched children and adolescents. However, we identified some Japanese children with nonobese type 2 diabetes and BMI less than 90th centile by a urine glucose screening program at schools in the Tokyo Metropolitan Area. According to the results obtained from the screening, clinical characteristics of patients with nonobese type 2 diabetes seemed to be different from those in obese type 2 diabetes. Nonobese patients tended to show lower insulin secretion abilities and milder, but evident, insulin resistance from the time of diagnosis. Female, low birth weight (small for gestational age), and genetic background, not related to β-cell-associated autoimmunity, may play a role in development of nonobese type 2 diabetes. In addition, nonobese patients tend to progress earlier to pharmacological treatment including oral hypoglycemic drugs and insulin. Further studies are needed to confirm to these findings and clarify the pathophysiology of children with nonobese type 2 diabetes.
众所周知,全球青少年2型糖尿病的发病率正在上升。另一方面,大多数研究表明,大多数青少年2型糖尿病发生在肥胖个体中,一般体重指数(BMI)高于性别和年龄匹配的儿童及青少年的第90或第95百分位数。然而,我们通过东京都地区学校的尿液葡萄糖筛查项目,发现了一些BMI低于第90百分位数的非肥胖型2型糖尿病日本儿童。根据筛查结果,非肥胖型2型糖尿病患者的临床特征似乎与肥胖型2型糖尿病患者不同。非肥胖患者从诊断时起往往表现出较低的胰岛素分泌能力以及较轻但明显的胰岛素抵抗。女性、低出生体重(小于胎龄)以及与β细胞相关自身免疫无关的遗传背景,可能在非肥胖型2型糖尿病的发生中起作用。此外,非肥胖患者往往更早进展为包括口服降糖药和胰岛素在内的药物治疗。需要进一步研究来证实这些发现,并阐明非肥胖型2型糖尿病儿童的病理生理学。